Roman Zenouzi

1.7k total citations
27 papers, 851 citations indexed

About

Roman Zenouzi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Roman Zenouzi has authored 27 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 20 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Roman Zenouzi's work include Liver Diseases and Immunity (23 papers), Liver Disease Diagnosis and Treatment (20 papers) and Gallbladder and Bile Duct Disorders (9 papers). Roman Zenouzi is often cited by papers focused on Liver Diseases and Immunity (23 papers), Liver Disease Diagnosis and Treatment (20 papers) and Gallbladder and Bile Duct Disorders (9 papers). Roman Zenouzi collaborates with scholars based in Germany, United States and Netherlands. Roman Zenouzi's co-authors include Christoph Schramm, Ansgar W. Lohse, Hanno Ehlken, Marcial Sebode, Christina Weiler‐Normann, Johannes Hartl, Moritz Peiseler, Nadine Pannicke, Timur Liwinski and U Denzer and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Gut.

In The Last Decade

Roman Zenouzi

27 papers receiving 840 citations

Peers

Countries citing papers authored by Roman Zenouzi

Since Specialization

Citations

This map shows the geographic impact of Roman Zenouzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Zenouzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Zenouzi more than expected).

Fields of papers citing papers by Roman Zenouzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Zenouzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Zenouzi. The network helps show where Roman Zenouzi may publish in the future.

Co-authorship network of co-authors of Roman Zenouzi

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Zenouzi. A scholar is included among the top collaborators of Roman Zenouzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Zenouzi. Roman Zenouzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug‐induced liver injury at a tertiary care centre in Germany: Model for end‐stage liver disease is the best predictor of outcome 2021 ·Liver International ·(unknown), Roman Zenouzi, (unknown), Till Krech, Sören Weidemann, Martina Sterneck, Christina Weiler‐Normann, Ansgar W. Lohse, Christoph Schramm, Marcial Sebode	12
2	Features and outcome of AIH patients without elevation of IgG 2020 ·JHEP Reports ·Johannes Hartl, Rosa Miquel, Kalliopi Zachou, (unknown), Asma Asghar, Simon Pape, Marcial Sebode, Moritz Peiseler, Roman Zenouzi, Hanno Ehlken, Till Krech, Christina Weiler‐Normann, Joost P.H. Drenth, Ye Htun Oo, George Ν. Dalekos, Michael A. Heneghan, Christoph Schramm, Ansgar W. Lohse	34
3	Alterations of the bile microbiome in primary sclerosing cholangitis 2019 ·Gut ·Timur Liwinski, Roman Zenouzi, Clara John, Hanno Ehlken, Malte Rühlemann, Corinna Bang, Stefan Groth, Wolfgang Lieb, Marcus Kantowski, Nils M. Andersen, Guido Schachschal, Tom H. Karlsen, Johannes R. Hov, Thomas Rösch, Ansgar W. Lohse, Jöerg Heeren, André Franke, Christoph Schramm	96
4	Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis 2018 ·PLoS ONE ·Moritz Peiseler, (unknown), Hans O. Pinnschmidt, Marcial Sebode, (unknown), Johannes Hartl, Roman Zenouzi, Hanno Ehlken, Stefan Groth, Guido Schachschal, Thomas Rösch, Christina Weiler‐Normann, Ansgar W. Lohse, Christoph Schramm	10
5	Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis 2018 ·PLoS ONE ·Sarah Keller, Annette Aigner, Roman Zenouzi, (unknown), (unknown), Sören Weidemann, Till Krech, Ansgar W. Lohse, Gerhard Adam, Christoph Schramm, Jin Yamamura	10
6	Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure 2018 ·PLoS ONE ·Roman Zenouzi, Janina von der Gablentz, Marcus Heldmann, Martin Göttlich, Christina Weiler‐Normann, Marcial Sebode, Hanno Ehlken, Johannes Hartl, (unknown), Susanne Siemonsen, Christoph Schramm, Thomas F. Münte, Ansgar W. Lohse	13
7	Gadolinium-based relative contrast enhancement in primary sclerosing cholangitis: additional benefit for clinicians? 2018 ·Clinical Radiology ·Sarah Keller, Sudhakar K. Venkatesh, Maxim Avanesov, Julius Matthias Weinrich, Roman Zenouzi, Christoph Schramm, Gerhard Adam, Jin Yamamura	5
8	Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis 2018 ·European Radiology ·Sarah Keller, Jan Sedlacik, (unknown), Ralph Buchert, Maxim Avanesov, Roman Zenouzi, Ansgar W. Lohse, Hendrik Kooijman, Jens Fiehler, Christoph Schramm, Jin Yamamura	14
9	Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 2018 ·Alimentary Pharmacology & Therapeutics ·Roman Zenouzi, Timur Liwinski, Jin Yamamura, (unknown), Marcial Sebode, Sune H. Keller, Ansgar W. Lohse, Christoph Schramm, (unknown)	34
10	Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis 2017 ·Current Opinion in Gastroenterology ·Hanno Ehlken, Roman Zenouzi, Christoph Schramm	18
11	Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis 2017 ·Clinical Gastroenterology and Hepatology ·Moritz Peiseler, (unknown), Marcial Sebode, Roman Zenouzi, Johannes Hartl, Hanno Ehlken, Nadine Pannicke, Christina Weiler‐Normann, Ansgar W. Lohse, Christoph Schramm	42
12	Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis 2017 ·Journal of Hepatology ·Johannes Hartl, Hanno Ehlken, Marcial Sebode, Moritz Peiseler, Till Krech, Roman Zenouzi, Johann von Felden, Christina Weiler‐Normann, Christoph Schramm, Ansgar W. Lohse	82
13	Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis 2016 ·Journal of Hepatology ·Johannes Hartl, U Denzer, Hanno Ehlken, Roman Zenouzi, Moritz Peiseler, Marcial Sebode, (unknown), Nadine Pannicke, Christina Weiler‐Normann, Alexander Quaas, Ansgar W. Lohse, Christoph Schramm	121
14	No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis 2016 ·Clinical Gastroenterology and Hepatology ·Roman Zenouzi, Tobias J. Weismüller, Kristin Kaasen Jørgensen, Michaël Bubenheim, Henrike Lenzen, Peter Hübener, Kornelius Schulze, Christina Weiler‐Normann, Marcial Sebode, Hanno Ehlken, Nadine Pannicke, Johannes Hartl, Moritz Peiseler, (unknown), Tom H. Karlsen, Kirsten Muri Boberg, Michael P. Manns, Ansgar W. Lohse, Christoph Schramm	12
15	Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis 2016 ·PLoS ONE ·Hanno Ehlken, (unknown), Christophe Corpechot, Lionel Arrivé, (unknown), Johannes Hartl, Susanne Lezius, Peter Hübener, Kornelius Schulze, Roman Zenouzi, Marcial Sebode, Moritz Peiseler, U Denzer, Alexander Quaas, Christina Weiler‐Normann, Ansgar W. Lohse, Olivier Chazouillères, Christoph Schramm	51
16	Increased in vivo and in vitro TH17 differentiation in patients with Primary Sclerosing Cholangitis 2016 ·Zeitschrift für Gastroenterologie ·(unknown), Tanja Schoknecht, Stephanie Stein, Hanno Ehlken, Johannes Hartl, Nadine Pannicke, Moritz Peiseler, Marcial Sebode, Christina Weiler‐Normann, Roman Zenouzi, AW Lohse, Johannes Herkel, Dorothee Schwinge, Christoph Schramm	1
17	Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis 2014 ·Clinical Gastroenterology and Hepatology ·Roman Zenouzi, Tobias J. Weismüller, Peter Hübener, Kornelius Schulze, Michaël Bubenheim, Nadine Pannicke, (unknown), Henrike Lenzen, Michael P. Manns, Ansgar W. Lohse, Christoph Schramm	65
18	Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis 2014 ·Journal of Hepatology ·Johannes Hartl, Hanno Ehlken, Christina Weiler‐Normann, Marcial Sebode, Benno Kreuels, Nadine Pannicke, Roman Zenouzi, C Glaubke, Ansgar W. Lohse, Christoph Schramm	68
19	Der pyogene Leberabszess: eine retrospektive Patientenstudie 2012 ·Zeitschrift für Gastroenterologie ·Roman Zenouzi, Stefan Schmiedel, Ansgar W. Lohse	1
20	Bupivacaine Destabilizes Action Potential Duration in Cellular and Computational Models of Long QT Syndrome 1 2011 ·Anesthesia & Analgesia ·Alexander Peter Schwoerer, Roman Zenouzi, Heimo Ehmke, Patrick Friederich	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact